Your session is about to expire
← Back to Search
Circulating DNA Analysis for Soft Tissue Sarcoma
Study Summary
This trial will collect blood and tumor tissue samples to study circulating tumor DNA, which may be useful for cancer detection, predicting treatment response, and disease monitoring.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My cancer has spread to nearby lymph nodes or other parts of my body.I have not had cancer in the last 5 years, except for skin or early cervical cancer.I do not have any serious illnesses that would stop me from following the study's requirements.I have a confirmed diagnosis of a high-risk sarcoma in my limbs or abdomen.My tumor is non-cancerous.My doctors agree I should have surgery and radiation for my cancer.I am 18 years old or older.I can take care of myself and am up and about more than half of the day.I am scheduled for chemotherapy before surgery.
- Group 1: Soft Tissue Sarcoma
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the maximum capacity of patients for this research project?
"Affirmative. The information on clinicaltrials.gov reaffirms that this medical trial is actively seeking patients, commencing from January 17th 2019 and most recently updated April 11 2021. 40 participants are expected to be recruited over the course of one site."
Are there unfilled slots available for the trial's participants?
"Affirmative. The information posted on clinicaltrials.gov confirms that this trial is presently seeking participants, which were initially advertised on the 17th of January 2019 and have been updated as recently as the 11th April 2021. 40 patients must be sourced from one medical centre for participation in this study."
Share this study with friends
Copy Link
Messenger